Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
17-Jun-25 | Buy | Heather Preston | 324.00p | 11,389 | £36,900.36 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
17-Jun-25 | Buy | Heather Preston | 324.00p | 11,389 | £36,900.36 |
Notifier | Holding | Value* |
---|---|---|
Roch Doliveux | 309,808 | £1,361,606 |
Heather Preston | 29,687 | £130,474 |
Frank Mathias | 20,000 | £87,900 |
Namrata P Patel | 9,170 | £40,302 |
Dame Kay Davies | 1,000 | £4,395 |
Notifier** | Holding | Value* |
---|---|---|
Briarwood Chase Management LLC | 13,851,927 | £60,879,219 |
Novo Nordisk Foundation | 12,048,802 | £52,954,485 |
Institut Merieux SA | 11,510,481 | £50,588,564 |
Briarwood Chase Management LLC | 11,171,966 | £49,100,791 |
VULPES LIFE SCIENCES FUND | 8,447,390 | £37,126,279 |
Liontrust Asset Management | 6,078,799 | £26,716,322 |
M&G Plc | 5,872,847 | £25,811,163 |
Legal & General Group Plc | 5,760,126 | £25,315,754 |
HSBC Global Custody Nominee (UK) Ltd | 4,700,000 | £20,656,500 |
Ameriprise Financial, Inc. | 4,108,146 | £18,055,302 |
Columbia Threadneedle Investments (London) | 3,834,977 | £16,854,724 |
Canaccord Genuity Group Inc | 3,699,438 | £16,259,030 |
Hargreaves Lansdown Asset Management | 3,475,237 | £15,273,667 |
SERUM LIFE SCIENCES LTD | 3,382,950 | £14,868,065 |
Nine Ten Capital | 3,117,228 | £13,700,217 |
Lansdowne Partners (London) | 3,085,765 | £13,561,937 |
Mr. S Shah | 2,898,750 | £12,740,006 |
Artisan Partners | 2,620,800 | £11,518,416 |
Cubana Investments Limited | 2,506,000 | £11,013,870 |
Interactive Investor Sharedealing | 2,372,412 | £10,426,751 |
TDWaterhouse | 852,076 | £3,744,874 |
Self Trade Stockbrokers | 657,039 | £2,887,686 |
Currency | UK Pounds |
Share Price | 439.50p |
Change Today | -4.50p |
% Change | -1.01 % |
52 Week High | 464.50 |
52 Week Low | 232.50 |
Volume | 100,317 |
Shares Issued | 106.20m |
Market Cap | £466.75m |
Beta | 0.02 |
RiskGrade | 125 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 10 |
No dividends found |
Time | Volume / Share Price |
17:07 | 334 @ 442.66p |
17:07 | 369 @ 442.66p |
17:07 | 733 @ 442.66p |
17:07 | 2,979 @ 442.66p |
15:48 | 160 @ 443.50p |
Chair | Roch Doliveux |
CEO | Frank Mathias |
CFO | Lucinda (Lucy) Crabtree |
You are here: research